Detalhe da pesquisa
1.
Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
Microb Cell Fact
; 14: 19, 2015 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889802
2.
Magneto-plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging.
Small
; 10(12): 2476-86, 2014 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619736
3.
Reductive activation of type 2 ribosome-inactivating proteins is promoted by transmembrane thioredoxin-related protein.
J Biol Chem
; 287(10): 7367-73, 2012 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22228764
4.
Cloning and characterization of canine prostate-specific membrane antigen.
Prostate
; 73(6): 642-50, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359458
5.
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.
Mol Ther
; 19(10): 1858-66, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792178
6.
Pichia pastoris as a host for secretion of toxic saporin chimeras.
FASEB J
; 24(1): 253-65, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19786581
7.
SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells.
Sci Rep
; 10(1): 15805, 2020 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978492
8.
Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes.
Biochem J
; 409(1): 149-57, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17935484
9.
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Theranostics
; 9(10): 2924-2938, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31244933
10.
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.
J Nucl Med
; 59(3): 494-501, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146698
11.
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia.
Nanoscale
; 10(3): 1272-1278, 2018 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29292448
12.
Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens.
Small
; 8(24): 3733-8, 2012 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927257
13.
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
Oncotarget
; 8(7): 10919-10930, 2017 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28051996
14.
In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.
Sci Rep
; 6: 23314, 2016 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996325
15.
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".
Oncotarget
; 7(45): 74189-74202, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27713116
16.
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection.
Biosens Bioelectron
; 72: 393-9, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025134
17.
Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
Contrast Media Mol Imaging
; 10(1): 28-36, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24764162
18.
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Biochem Pharmacol
; 67(9): 1721-31, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15081871
19.
Immunotoxins and other conjugates: preparation and general characteristics.
Mini Rev Med Chem
; 4(5): 545-62, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15180510
20.
PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models.
PLoS One
; 9(10): e109427, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25279468